首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2517篇
  免费   63篇
  国内免费   4篇
林业   71篇
农学   26篇
基础科学   18篇
  255篇
综合类   1219篇
农作物   76篇
水产渔业   100篇
畜牧兽医   677篇
园艺   38篇
植物保护   104篇
  2023年   6篇
  2022年   12篇
  2021年   20篇
  2020年   24篇
  2019年   26篇
  2018年   25篇
  2017年   18篇
  2016年   17篇
  2015年   23篇
  2014年   23篇
  2013年   70篇
  2012年   102篇
  2011年   132篇
  2010年   73篇
  2009年   62篇
  2008年   137篇
  2007年   129篇
  2006年   143篇
  2005年   149篇
  2004年   140篇
  2003年   132篇
  2002年   128篇
  2001年   53篇
  2000年   52篇
  1999年   18篇
  1998年   16篇
  1997年   11篇
  1996年   16篇
  1995年   41篇
  1994年   47篇
  1993年   46篇
  1992年   41篇
  1991年   54篇
  1990年   44篇
  1989年   55篇
  1988年   56篇
  1987年   50篇
  1986年   54篇
  1985年   54篇
  1984年   46篇
  1983年   40篇
  1982年   46篇
  1981年   31篇
  1980年   25篇
  1979年   19篇
  1978年   21篇
  1975年   6篇
  1974年   5篇
  1967年   7篇
  1963年   4篇
排序方式: 共有2584条查询结果,搜索用时 15 毫秒
1.
Hematology and serum biochemistry values are reported for 33 Attwater's prairie chickens (Tympanuchus cupido attwateri) that were captive-reared at the San Antonio Zoo as part of a federal reintroduction program in Texas. Hematologic values include packed cell volume, and total and differential white blood cell counts. The biochemical values include concentrations of serum calcium, total protein, albumin, phosphorus, glucose, uric acid, and cholesterol. Mathematic computation of globulin concentration and albumin: globulin ratios were conducted. Also, determination of the serum activities of creatine kinase and aspartate aminotransferase was done.  相似文献   
2.
3.
Decapsulation of Artemia spp. cysts in strong hypochlorite solutions reportedly increases the number of nauplii that hatch. Commercial cysts of Artemia franciscano were subjected to four decapsulation methods prior to hatching them in aerated seawater. Samples were removed from the hatch vessels every 5 h from 15 through 45 h, and fully hatched nauplii were counted. The experiment was performed three times. No significant difference was seen between mean numbers of control nauplii and nauplii obtained using the decapsulation method that yielded the best hatch: oxidation for 15 min in equal parts Clorox® and seawater plus 6 mL of a 40% NaOH solution, followed by reduction with 100 mL of 0.7 M sodium thiosulfate. A third treatment was inferior to either of these, and two others produced very low yields. It was concluded that of the methods evaluated, none is superior to no treatment at all, and some are clearly detrimental to developing Artemia embryos.  相似文献   
4.
5.
6.
7.
8.
Blood and bone marrow smears from 49 dogs and cats, believed to have myeloproliferative disorders (MPD), were examined by a panel of 10 clinical pathologists to develop proposals for classification of acute myeloid leukemia (AML) in these species. French-American-British (FAB) group and National Cancer Institute (NCI) workshop definitions and criteria developed for classification of AML in humans were adapted. Major modifications entailed revision of definitions of blast cells as applied to the dog and cat, broadening the scope of leukemia classification, and making provisions for differentiating erythremic myelosis and undifferentiated MPD. A consensus cytomorphologic diagnosis was reached in 39 (79.6%) cases comprising 26 of AML, 10 of myelodysplastic syndrome (MDS), and 3 of acute lymphoblastic leukemia (ALL). Diagnostic concordance for these diseases varied from 60 to 81% (mean 73.3 +/- 7.1%) and interobserver agreement ranged from 51.3 to 84.6% (mean 73.1 +/- 9.3%). Various subtypes of AML identified included Ml, M2, M4, M5a, M5b, and M6. Acute undifferentiated leukemia (AUL) was recognized as a specific entity. M3 was not encountered, but this subclass was retained as a diagnostic possibility. The designations M6Er and MDS-Er were introduced where the suffix "Er" indicated preponderance of erythroid component. Chief hematologic abnormalities included circulating blast cells in 98% of the cases, with 36.7% cases having >30% blast cells, and thrombocytopenia and anemia in approximately 86 to 88% of the cases. Bone marrow examination revealed panmyeloid dysplastic changes, particularly variable numbers of megaloblastoid rubriblasts and rubricytes in all AML subtypes and increased numbers of eosinophils in MDS. Cytochemical patterns of neutrophilic markers were evident in most cases of Ml and M2, while monocytic markers were primarily seen in M5a and M5b cases. It is proposed that well-prepared, Romanowsky-stained blood and bone marrow smears should be examined to determine blast cell types and percentages for cytomorphologic diagnosis of AML. Carefully selected areas of stained films presenting adequate cellular details should be used to count a minimum of 200 cells. In cases with borderline diagnosis, at least 500 cells should be counted. The identity of blast cells should be ascertained using appropriate cytochemical markers of neutrophilic, monocytic, and megakaryocytic differentiation. A blast cell count of > 30% in blood and/or bone marrow indicates AML or AUL, while a count of < 30% blasts in bone marrow suggests MDS, chronic myeloid leukemias, or even a leukemoid reaction. Myeloblasts, monoblasts, and megakaryoblasts comprise the blast cell count. The FAB approach with additional criteria should be used to distinguish AUL and various subtypes of AML (Ml to M7 and M6Er) and to differentiate MDS, MDS-ER, chronic myeloid leukemias, and leukemoid reaction. Bone marrow core biopsy and electron microscopy may be required to confirm the specific diagnosis. Immunophenotyping with lineage specific antibodies is in its infancy in veterinary medicine. Development of this technique is encouraged to establish an undisputed identity of blast cells. Validity of the proposed criteria needs to be substantiated in large prospective and retrospective studies. Similarly, clinical relevance of cytomorphologic, cytochemical, and immunophenotypic characterizations of AML in dogs and cats remains to be determined.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号